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ABSTRACT
Introduction: With the ageing of the population and
the general improvement of care, an increasing number
of people are living with multiple chronic health
conditions or ‘multimorbidity’. Multimorbidity often
implies multiple medical treatments. As a consequence,
the risk of adverse events and the time spent by
patients for their treatments increase exponentially. In
many cases, treatment guidelines traditionally defined
for single conditions are not easily applicable. Primary
care for individuals with multimorbidity requires
complex patient-centred care and good communication
between the patient and the general practitioner (GP).
This often includes prioritising among the different
chronic conditions.
Methods and analysis: The main objectives of this
study are to describe the burden related to multimorbidity
(disease-related burden and burden of treatment) in
primary care and to identify the factors influencing it.
Other objectives include evaluating patients’ perception of
treatment burden and quality of life, assessing factors
influencing that perception, and investigating
prioritisation in the management of multimorbidity from
the perspectives of GPs and patients. For this cross-
sectional study, patient enrolment will take place in GP’s
private practices across Switzerland. A convenient
sample of 100 GPs will participate; overall, 1000 patients
with at least three chronic health conditions will be
enrolled. Data will be collected as paper-based
questionnaires for GPs and delayed telephone interview
questionnaires for patients. GPs will provide
demographic and practice-related data. In addition, each
GP will complete a paper-based questionnaire for each
patient that they enrol. Each patient will complete a
telephone interview questionnaire.
Ethics and dissemination: This study has been
approved by the research ethics committee of Canton
Vaud, Switzerland (Protocol 315/14). The results of the
study will be reported in international peer-reviewed
journals.
INTRODUCTION
Prevalence of multimorbidity in primary care
Multimorbidity is deﬁned as the co-occur-
rence of chronic medical conditions within
one person without a single condition being
considered the main condition.1 Caring for
multimorbid patients is an important part of
general practice. A large population-based
study conducted in the UK estimated that
42.2% of the population visiting a general
practitioner (GP), including children, had at
least one chronic health condition; 23.2%
had at least two chronic conditions.2 Other
studies estimated the prevalence of multi-
morbidity in primary care between 13% and
75.5% depending on the population, the age
group considered, and the deﬁnition of mul-
timorbidity applied.3–8 The prevalence of
multimorbidity is inﬂuenced by different
factors, including age and socioeconomic
status (SES).2 9 10 Multiple chronic condi-
tions are more prevalent in the elderly, and
multimorbidity develops 10–15 years earlier
in the most deprived areas.2 11 The ageing of
the population, together with the improve-
ment of medical services, has led to the
increased survival of people with chronic
conditions and to an increased prevalence of
multimorbidity.12 Uijen and Van de
Lisdonk12 observed, on data from a registry
including 10 GPs and approximately 13 500
patients, that the proportion of patients with
at least four chronic conditions tripled
between 1985 and 2005.
Disease-related burden and burden of
treatment
Cumulative effects of multiple chronic condi-
tions can be expressed in terms of
disease-related burden, or burden of treat-
ment. Studies suggest that the cumulative
effect of chronic health conditions is not
simply incremental; speciﬁc combinations of
conditions may have a greater effect on func-
tional status, quality of life and mortality
than others.13 14 The burden of treatment
itself encompasses different aspects, such as
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the number of investigations, number of pills to take
each day, number of injections to take, number of
check-ups or preventive measures, and other care (eg,
education or physiotherapy). For instance, an estimated
20% of older adults in the US population take more
than 10 different medications each week.15 16 Owing to
the importance of the disease-related burden and
burden of treatment, primary care for people with multi-
morbidity must address disease-speciﬁc issues in the
context of coexisting chronic medical conditions and
the patient’s psychosocial environment. This implies
complex, patient-centered care involving patient–pro-
vider concordance, effective communication and shared
decision-making.17 18 One of the main difﬁculties GPs
face is the challenge of following guidelines that are typ-
ically developed for single diseases.19–21 Sinnott et al22
synthesised qualitative research on the perception that
GPs and other primary care practitioners have of the
management of multimorbidity. Ten studies conducted
in seven countries (Belgium, England, Germany,
Ireland, Scotland, the Netherlands and the USA),
including 275 GPs, were considered. The synthesis
emphasised that difﬁculties in the care of people with
multimorbidity mainly arise from disorganisation and
fragmentation of healthcare, inadequacy of guidelines
and evidence-based medicine, and challenges to patient-
centered care and shared decision-making.22
Prioritisation of care
Prioritisation of illnesses and care for speciﬁc diseases
should be concordant between patients and their GPs,
but may not always be. To date, few studies have
addressed prioritisation of care in multimorbid
patients.18 23 We identiﬁed a single study that examined
the prioritisation of care in multimorbid patients from
the patients’ perspective and without an index condi-
tion.23 Health outcome priorities (staying alive, main-
taining independence, reducing/eliminating pain and
reducing/eliminating symptoms) were evaluated.
Maintaining independence was ranked as the most
important factor by 76% of the patients. Among those
who ranked maintaining independence as the primary
factor, 67% ranked symptoms relief as the second.
Among those who ranked staying alive as their ﬁrst
concern (11%), 66% ranked maintaining independence
as their second concern. A single prospective study
including 92 providers and 1004 US veterans examined
the correlation between GPs’ and patient’s prioritisation
of health conditions.18 Patients and GPs provided the
three most important concerns among a list of nine con-
ditions chosen based on their prevalence (symptomatic
chronic conditions: pain, depression, breathing difﬁcul-
ties; and asymptomatic chronic conditions: hyperten-
sion, diabetes, hyperlipidaemia, heart disease or heart
failure, obesity and tobacco use). In 72% of cases, the
patient’s most important concern was represented in the
GP’s list of three most important concerns. In 60% of
the cases, there was a concordance between the patient’s
and the GP’s prioritisation. Concordance was lower
among patients who reported poor health status.18
Our aim is to assess the burden related to multimor-
bidity and to describe prioritisation in the management
of multiple chronic conditions in the context of primary
care practice, taking patients’ and GPs’ perspectives into
account.
METHODS AND ANALYSES
Study objectives
Primary objective 1: Burden related to multimorbidity—We will
assess the importance of the burden related to multi-
morbidity (ie, disease-related burden and burden of
treatment) among patients in a primary care setting,
identify the determinants of an increased burden
related to multimorbidity, and examine the agreement
between patients’ and GPs’ perceptions of this burden.
Primary objective 2: Prioritisation of care—We want to evalu-
ate the concordance between the problems related to the
prioritisation of treatment for multiple chronic conditions
as assessed by GPs and as perceived by patients. We will
assess prioritisation established by patients and by GPs in
the handling of chronic conditions among multimorbid
patients in primary care, and identify patient-related or
GP-related determinants that inﬂuence this prioritisation
achieved by patients and GPs, respectively.
Secondary objective: Gender study—We will examine
whether the gender of GPs or patients is a determinant
of variations in patients’ and GPs’ perceived burden in
relation to multimorbidity, and its related treatment in
primary care.
Study design
This is an observational study with a cross-sectional
design.
Study population
Participants: The study will involve GPs throughout
Switzerland and their multimorbid patients. We will enrol
1000 patients through a convenience sample of 100 GPs in
private practice. Each participating Institute of Family
Medicine will organise the recruitment of 20 GPs from
small or large practices in both urban and rural settings, in
their respective regions of Switzerland (ﬁgure 1). As no
Institute of Family Medicine exists in the Italian-speaking
part of the country, we restricted our study to the
French-speaking and German-speaking regions.
Eligibility: All multimorbid patients visiting a participat-
ing GP during the inclusion period and meeting the
inclusion criteria are eligible. We considered three
chronic conditions as the minimum number of condi-
tions for which a prioritisation of care could be necessary.
Inclusion criteria
▸ To be aged 18 years or older;
▸ To have been followed by the GP for at least
6 months before the index encounter;
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▸ To have enough knowledge of French or German to
be able to complete the questionnaire;
▸ To suffer from at least three chronic conditions iden-
tiﬁed from a list of 75 conditions (table 1);
▸ To consent to participate in the study and to sign the
informed consent form.
Exclusion criteria
▸ To suffer from a major cognitive or psychiatric dis-
order, and as such be unable to answer the
questionnaire;
▸ To be unable to read and/or to understand French
or German;
▸ To suffer from an emergency or acute life-threatening
condition (physical or psychological);
▸ To refuse to participate to the study after initial
approval and consent.
Sampling
Recruitment of patients (ﬁgure 2): Each GP will include 10
patients meeting the inclusion criteria. Recruitment will
take part over a maximum period of 10 weeks per GP.
The data collection process will start on 12 January 2015
and will end on 30 September 2015. Each GP will be
provided a randomisation calendar specifying which
patient to enrol for each half-day of the recruitment
weeks. We selected half-days for the recruitment of
patients to match GPs’ schedule as accurately as possible,
and to take into account the fact that many GPs work
either part-time or have a variety of professional activities
(teaching, home visits, etc). We wanted to make sure
that the GP was seeing patients at his practice during
the entire time slot considered. Patients’ recruitment is
based on patients who are scheduled for each half-day
of recruitment. The randomisation calendar gives the
ordered number of the consultation to consider, and
Figure 1 Schematic representation of the regions of Switzerland covered by each Institute of Family Medicine. Each Institute of
Family Medicine (Geneva, Lausanne, Bern, Basel, Zürich) will organise the enrolment of 20 general practitioners (GPs) located
within its region.
Table 1 Number of items in each category of the ICPC-2
used to identify multimorbid patients
ICPC-2 category
Number of
items
General and unspecified 3
Blood, blood forming organs and immune
mechanism
3
Digestive 7
Endocrine/metabolic and nutritional 5
Neurological 10
Skin 1
Musculoskeletal 4
Urological 3
Respiratory 4
Eye 3
Ear 2
Cardiovascular 10
Psychological 17
Female genital 2
Male genital 1
ICPC-2, International Classification of Primary Care, V.2.
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the GP includes the patient of this consultation if he/
she meets the inclusion criteria. If the randomised
patient does not meet the inclusion criteria, the next
patient who fulﬁls the inclusion criteria is eligible. If no
patient is included at the end of the half-day, the recruit-
ment process will be postponed to the next half-day of
consultations. The patient will be asked to consent to
participate to a telephone interview questionnaire that
will take place within 48 h after the visit to the GP. The
patient’s name and phone number will then be transmit-
ted to a research assistant. If an eligible patient refuses
to participate, their date of birth, sex and reason for
refusing participation will be documented.
Procedure (ﬁgure 2): Once the GP agrees to participate,
he/she will be trained by a research assistant or an inves-
tigator to ensure the aim of the study and data collection
processes are clearly understood. Training will include
detailed information on the procedure to follow, include
patients using the randomisation calendar, and the list
of 75 conditions provided. GPs will also be instructed on
the data collection process using the questionnaires.
Data collection from GPs will take place at the GPs’
Figure 2 General practitioners’ (GPs’) and patients’ recruitment process and general study procedure.
4 Déruaz-Luyet A, et al. BMJ Open 2015;5:e009165. doi:10.1136/bmjopen-2015-009165
Open Access
private practices using paper-based questionnaires. For
patients, we will use delayed phone interview question-
naires. Each GP will ﬁrst complete a survey providing
demographic and practice-related data. Patient enrol-
ment will take place during a visit to the GP. Randomly
identiﬁed patients will be informed of the study by their
GP and if they agree to take part, they will provide
written informed consent. Enrolled patients will com-
plete a 25 min telephone-based questionnaire. For each
patient who is enrolled, the GP will complete a 20 min
paper-based questionnaire. All data will be coded during
the data collection process. Patients’ names and phone
Table 2 All variables collected using the three different questionnaires
Variable Measure
GP-related variables (paper-based questionnaire)
Age Date of birth
Sex Sex
Place of graduate training City, country
Place of postgraduate training City, country
Type of practice Independent/on-a-contract GP, group practice, healthcare network
Years of practice 1 Year medical diploma was obtained
Years of practice 2 Year started independent practice
Other activity Aside from medical practice (eg, research; teaching; practice in a specific context, such
as prison, hospice for elders, school in a company, etc)
City/countryside Location of the practice (urban, sub-urban, rural) + zipcode
Number of consultations Mean number of consults per week
Mean age of patients Mean age of patients in the practice population as determined using the electronic
filing or electronic billing system
Subspecialty Medical board specialty other than that of General Internal Medicine
Patient-related variables assessed through the GP survey (paper-based questionnaire)
Age Date of birth
Sex Sex
Visits to GP in the last year Number of visits to the GP in the last 12 months
Visits to GP in the last month Number of visits to the GP in the last month
Time followed by GP Number of years that the patient has been treated by the GP
Hospitalisations Number of hospitalisations in the last 12 months
Number of chronic conditions Number of chronic conditions from the list provided
List of chronic conditions List of chronic conditions by decreasing order of importance
Conditions important to the patient List of the 3 chronic conditions the most important to the patient, according to the GP
Severity of each chronic condition Evaluated using the cumulative illness rating scale
Treatment Current treatment plan
Renouncement Conditions voluntarily left untreated or suboptimally treated by the GP
Interdisciplinarity Specialist MD/nurse/physiotherapist/rehabilitation therapist/caregiver
Treatment burden Subjective estimation of the patient’s treatment burden on a 0 to 10 scale (0= burden
not important at all; 10= very important burden)
Patient-related variables assessed through the patient survey (telephone interview questionnaire)
Age Date of birth
Sex Sex
Marital status Patient’s marital status (single, married, separated or divorced, widow(er))
Place of education City, country
Mother tongue Patient’s first language(s)
Education Highest schooling level achieved (primary school, secondary school, practical training,
high school or equivalent, superior degree non-university, university, other)
Size of the household/living situation Number of adults (≥18 years old) and children (<18 years old) living with the patient
Number of MDs Number of medical doctors (GPs and specialists) involved in the patient’s treatment
Medical and social assistance Does the patient receive medical and/or social assistance?
Pillbox Use of a pillbox (Y/N)
Interdisciplinarity Cleaning help or meal delivery system
Health literacy Health literacy will be assessed using the short 6-item HLS-EU questionnaire
Prioritisation Most important and second most important conditions
Quality of life Quality of life will be assessed using the EQ-5D-3L questionnaire
SES SES will be assessed using the DipCare questionnaire
Treatment burden Treatment burden will be assessed using the treatment burden questionnaire
GP, general practitioner; HLS-EU, The European Health Literacy Survey; SES, socioeconomic status.
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numbers will be destroyed after data collection is com-
pleted. Research assistants will conduct all patients’ tele-
phone interviews, in French or German, from the
Institute for Family Medicine in Lausanne. The research
team in Lausanne will train the research assistants to
conduct the telephone interviews and to collect the
data, in collaboration with the Pedagogical Unit of the
Faculty of Biology and Medicine of Lausanne. Training
will include conducting and handling phone interviews,
including the management of negative emotions that
may arise during the interview. A patient-actor will par-
ticipate in this training. The training will include learn-
ing to ask questions exactly as written on the
questionnaires to ensure homogeneity of the data collec-
tion between patients and between research assistants.
Research assistants will also be trained to record data
using the Epidata V.3.1 software.
Variables
We will collect GP-related and patient-related variables
(table 2). We describe the more complex variables
below. All questionnaires for which a German or French
version did not exist were translated using a translation/
back-translation procedure.
Patient-related variables assessed through the GP
survey include the number and list of chronic condi-
tions, severity of each chronic condition, current treat-
ment and renouncement of treatment.
Number and list of chronic conditions: The International
Classiﬁcation of Primary Care, V.2 (ICPC-2), is a classiﬁ-
cation of symptoms and diagnostics speciﬁcally designed
for use in primary care.24 We will employ a list of 75
chronic conditions identiﬁed in the ICPC-2 following a
methodology described elsewhere (N’Goran et al, in
preparation). Brieﬂy, we conducted a nationwide survey
of GPs using a modiﬁed Delphi method.25 We used
experts from ﬁve different regions: Basel, Bern, Geneva,
Vaud and Zürich. We started with all 686 items of the
ICPC-2 and proceeded to a step-by-step elimination.
First, a focus group of ﬁve experts removed from the
ICPC-2 items that were irrelevant in the context of
chronic conditions. Then, three rounds of online survey
were conducted: experts had to score the chronic aspect
of each remaining item ﬁrst as chronic, not chronic or
in between, and second on a scale of 1–9 (2 rounds);
and then assess the relevance of the chronic items in
the context of multimorbidity (1 round). To analyse
data, we used the median values and the inter-percentile
range adjusted for symmetry (IPRAS) for agreement/
disagreement between experts.25 Items reaching a
median value of 6 and agreement between experts were
retained in the ﬁnal list.
Severity of each chronic condition: For each patient
enrolled, the GP will provide a quantitative estimate of
impairment for each organ area using the cumulative
illness rating scale (CIRS).26 The CIRS involves rating
the impairment of 14 organs or systems. Medical pro-
blems are compiled and quantiﬁed by organ system,
resulting in the computation of a cumulative score that
represents the degree of impairment to the whole
person. The CIRS has been used in studies involving
multimorbid patients and been validated for use in
primary care.27–30
Current treatment: The GP will provide a list of all medi-
cations, preventive measures and rehabilitative measures
prescribed. The actual treatment will be considered.
Renouncement of treatment: The GP will provide a list of
conditions for which he/she consider the treatment as
suboptimal, because it had to be adapted due to poten-
tial drug interaction, treatment burden or lack of com-
pliance from the patient or following a shared decision
with the patient.
Patient-related variables assessed through the patients’
survey include prioritisation, quality of life, SES, health
literacy and treatment burden.
Prioritisation: We will assess the prioritisation of chronic
conditions from the patient’s perspective by asking if
he/she had the power to remove one health condition,
which one he/she would choose ﬁrst and then second.
It is possible that one or both answers to this question
will not refer to chronic conditions; however, we expect
this to be the case only for a restricted number of
patients.
Quality of life: We will evaluate the burden related to
multimorbidity from the patient’s perspective using the
EQ-5D-3L quality-of-life scale.31–33 The EQ-5D-3L is a
short, validated questionnaire for the self-assessment of
quality of life for which population reference values are
available for Switzerland.34 35
SES: The SES of enrolled patients will be assessed
using the deprivation in primary care questionnaire
(DipCare), which was developed and validated in the
French-speaking part of Switzerland36 and translated
into German. An overall score of deprivation will be
then computed.
Health literacy: We will use the six-item questionnaire
from the European Health Literacy Survey project
(HLS-EU 6) to assess health literacy.37 These items were
selected based on content and difﬁculty experienced
from the 47-question survey (HLS-EU 47).37 38 The
HLS-EU 6 was developed on a random subsample of the
HLS-EU 47 survey (N=3411), and cross-validated with
another random subsample (N=3383) (HLS-EU consor-
tium, personal communication, 2014). Answers to each
question from the HLS-EU 6 are given in the form of a
four-point Likert scale (1=very difﬁcult, 2=fairly difﬁcult,
3=fairly easy, 4=very easy). Although no population-based
data exist for Switzerland, data do exist for neighbouring
countries.
Treatment burden: The treatment burden questionnaire
(TBQ) was developed recently to assess the overall
burden related to the treatment of chronic conditions.39
It consists of 13 questions whose answers are each scored
from 0 to 10, with 0 corresponding to no burden and 10
to a very important/considerable burden. The global
(summed) score of treatment burden ranges from 0 to
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130. No Swiss population-based data exist for this
questionnaire.
Planned analyses
Primary objective 1: Burden related to multimorbidity
▸ To identify patient-related or GP-related determinants
that inﬂuence the disease-related burden (number of
chronic conditions, CIRS and EQ-5D-3L) or TBQ
▸ To analyse the relationship between the perceptions
of patients and the GPs regarding the burden related
to multimorbidity using the number of chronic con-
ditions identiﬁed, the CIRS and the EQ-5D-3L
questionnaire
▸ To assess the burden of treatment in terms of the
number of pills prescribed per day, and to test
whether it relates to the patients’ evaluation using the
TBQ, and to GPs’ evaluation of the burden of
treatment
▸ To assess whether the number of conditions treated is
related to TBQ scores using univariate and multivari-
ate models
Primary objective 2: Prioritisation of care
▸ To evaluate whether in multimorbid patients some
chronic conditions are left untreated by comparing
the list of chronic conditions diagnosed with the list
of treatments prescribed.
▸ To describe the subgroup of patients with conditions
left voluntarily untreated or suboptimally treated, and
compare it to the group of patients in which no con-
ditions were left untreated
▸ To test whether the two conditions classiﬁed as most
important by GPs and patients are concordant. We
will obtain a series of concordant and discordant
patients’/GPs’ pairs; describe and compare the sub-
groups of patients/GPs with concordant pairs versus
discordant pairs; and evaluate whether the concord-
ance between patients’ and GPs’ evaluations of the
most important chronic conditions correlates with
the TBQ scores.
▸ To identify the patient-related or GP-related determi-
nants that have an inﬂuence on concordance in the
prioritisation achieved by patients and GPs,
respectively.
Secondary objective: Gender study
▸ To examine whether gender of patients or GPs inﬂu-
ences the TBQ or the GPs’ evaluation of the burden
of treatment
▸ To examine whether gender inﬂuences the concord-
ance between GPs’ and patients’ prioritisations of
chronic conditions
Statistics
Patients’ sample size: The sample size estimation is based
on reported proportions of patients with different
numbers of chronic conditions from studies conducted
in primary care. We evaluated the number of patients
whom we would include with different numbers of
chronic conditions, given possible sample sizes of 500,
750 and 1000 patients, if the repartition of patients was
similar to that in any of the three studies considered.
Based on this data, a sample size of 1000 is enough to
allow for potential subgroup analyses. The estimates are
reported in table 3. This sample size is also coherent
considering that a statistical model requires approxi-
mately 15 patients per variable.
Descriptive statistics: Descriptive statistics will be per-
formed to describe the sample of GPs and the sample of
patients. All collected measures and derived variables
will be summarised using usual descriptive statistics and
the associated 95% CI. For categorical variables, the
description will consist (at minimum) of the sample size;
numbers of missing data; valid data, median, upper and
lower quartiles; and the frequency and percentage of
each category.
Exploratory data analysis: t-Test will be used for continu-
ous normally distributed variables; one-way analysis of vari-
ance will be used if we need to compare more than two
groups. For continuous variables not normally distributed,
Table 3 Estimates for sample size evaluation
Expected number
Reference
Coding
system
used Age, years
Number of
chronic
conditions
Number of
patients Percentage
Sample
size of 500
Sample
size of 750
Sample
size of
1000
Barnett et al, 20122 Read codes No age limit 3 99 487 0.418 209 314 418
4 60 417 0.254 127 190 254
5 35 641 0.150 75 112 150
6 20 507 0.086 43 65 86
7 11 080 0.047 23 35 47
≥8 10 846 0.046 23 34 46
Rizza et al, 201240 ICPC-2 ≥20 3 2319 0.48 240 360 480
>3 2513 0.52 260 187 520
Glynn et al, 20115 ICPC-2 >50 3 636 0.47 233 349 466
4 367 0.27 134 202 269
≥5 362 0.27 133 199 265
ICPC-2, International Classification of Primary Care, V.2.
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we will use non-parametric tests: the Mann-Whitney U test
to compare two groups, and the Kruskall-Wallis test to
compare three or more groups. For categorical variables,
we will employ the χ2 test or Fisher’s exact test, depending
on the number of observations obtained in each category
considered. All tests are two-sided unless otherwise speci-
ﬁed, and p<0.05 will be considered statistically signiﬁcant.
Correlation between variables will be assessed using the
Pearson correlation coefﬁcient for normally distributed
variables or the Spearman correlation otherwise. We will
evaluate the level of agreement between two of the same
parameter using agreement tables, scatter plots and
Cohen’s κ statistic.
Univariate tests will be used to select variables accord-
ing to the p value obtained (p<0.25) to include in the
multivariate analyses. For the multivariate analyses, gen-
eralised linear regression models will be used: Poisson
regression for outcome variables in the form of scores,
multinomial logistic regression for non-dichotomous cat-
egorical variables, or logistic regression for dichotomous
variables, as appropriate. Mixed effects multilevel
models that take clustering and between-site differences
into account will be considered. These models will
include two levels of clustering in order to take into
account the variability caused by regions and GPs.
Models will be compared and the best model will be
selected on the basis of likelihood ratio tests.
Ethical aspects
The study protocol and study documentation, including
all questionnaires and the informed consent, were
accepted by the ethical committee of the Canton of
Vaud acting as the lead ethical committee for
Switzerland. The protocol was then transmitted to the
local ethical commissions of the different regions
involved in the study.
We anticipate no direct beneﬁts for the patients.
Indirect beneﬁts include contribution to understanding
the mechanisms underlying the handling of patients
with multimorbidity, which will eventually improve the
management of patients. No important risk is foreseen
as a direct result of the survey. GPs will handle the
healthcare of included patients as normal.
Potential biases and limits
We will use a convenience sample of 100 GPs, and thus
will not follow a randomised sampling for the identiﬁca-
tion of GPs. As a result, participating GPs may not be rep-
resentative of the overall population of GPs practising in
Switzerland. Sociodemographic data collected, such as
sex, age and location of practice, will allow for the charac-
terisation of the participating GPs and the evaluation of
external validity. Recruitment of patients will follow a
strict randomised procedure, and no selection bias is
foreseen. In addition, demographic data will be collected
from patients who refuse to participate in the study, as
well as their reasons for non-participation. Data will
mainly be collected through self-assessment
questionnaires. This leaves the potential for information
bias. However, as both GPs and patients will have no
detailed knowledge of the objectives of the study, or of
the analyses planned, we anticipate that information bias
will not be signiﬁcant or will only lead to non-differential
misclassiﬁcation. We will use standardised tests of proven
high internal validity. However, for some tests, such as the
CIRS, the TBQ and the HLS-EU 6 questions, no data in
Switzerland have been reported, as yet. For tests for
which no Swiss data are available, data from populations
close to the Swiss population (German and French speak-
ing) are available. The TBQ test was developed and used
in a single French population. No German version has
been developed and used previously.
Pilot phase
A pilot phase is planned for this study. We will enrol ﬁve
pilot patients through a convenience sample of ﬁve GPs
across Switzerland based on their willingness to partici-
pate. We will ask each patient to complete the telephone
interview questionnaire and each GP to complete the
paper questionnaire. The pilot phase aims to evaluate
the feasibility of the study, to recognise and solve poten-
tial issues with the use of questionnaires, and to better
deﬁne speciﬁc aspects of the training of research
assistants.
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